Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 90 entries
Sorted by: Best Match Show Resources per page
Do Visual and Vestibular Inputs Compensate for Somatosensory Loss in the Perception of Spatial Orientation? Insights from a Deafferented Patient.

Frontiers in human neuroscience

Bringoux L, Scotto Di Cesare C, Borel L, Macaluso T, Sarlegna FR.
PMID: 27199704
Front Hum Neurosci. 2016 Apr 28;10:181. doi: 10.3389/fnhum.2016.00181. eCollection 2016.

The present study aimed at investigating the consequences of a massive loss of somatosensory inputs on the perception of spatial orientation. The occurrence of possible compensatory processes for external (i.e., object) orientation perception and self-orientation perception was examined by...

Cite
Bringoux L, Scotto Di Cesare C, Borel L, et al. Do Visual and Vestibular Inputs Compensate for Somatosensory Loss in the Perception of Spatial Orientation? Insights from a Deafferented Patient. Front Hum Neurosci. 2016;10:181doi: 10.3389/fnhum.2016.00181.
Bringoux, L., Scotto Di Cesare, C., Borel, L., Macaluso, T., & Sarlegna, F. R. (2016). Do Visual and Vestibular Inputs Compensate for Somatosensory Loss in the Perception of Spatial Orientation? Insights from a Deafferented Patient. Frontiers in human neuroscience, 10181. https://doi.org/10.3389/fnhum.2016.00181
Bringoux, Lionel, et al. "Do Visual and Vestibular Inputs Compensate for Somatosensory Loss in the Perception of Spatial Orientation? Insights from a Deafferented Patient." Frontiers in human neuroscience vol. 10 (2016): 181. doi: https://doi.org/10.3389/fnhum.2016.00181
Bringoux L, Scotto Di Cesare C, Borel L, Macaluso T, Sarlegna FR. Do Visual and Vestibular Inputs Compensate for Somatosensory Loss in the Perception of Spatial Orientation? Insights from a Deafferented Patient. Front Hum Neurosci. 2016 Apr 28;10:181. doi: 10.3389/fnhum.2016.00181. eCollection 2016. PMID: 27199704; PMCID: PMC4848302.
Copy Download .nbib Format: NLM
Effect of combined feeding stimuli on ingestion by the nematodeTrichostrongylus colubriformis.

Journal of chemical ecology

Bottjer KP, Bone LW.
PMID: 24306404
J Chem Ecol. 1986 Jan;12(1):147-54. doi: 10.1007/BF01045598.

Ingestion by the nematodeTrichostrongylus colubriformis was stimulated by serotonin, histamine, and dopamine. Immune serum inhibited feeding by both sexes while octopamine depressed feeding by only male nematodes. However, the combined influence of these excitatory and inhibitory stimuli is unknown....

Cite
Bottjer KP, Bone LW. Effect of combined feeding stimuli on ingestion by the nematodeTrichostrongylus colubriformis. J Chem Ecol. 1986;12(1):147-54doi: 10.1007/BF01045598.
Bottjer, K. P., & Bone, L. W. (1986). Effect of combined feeding stimuli on ingestion by the nematodeTrichostrongylus colubriformis. Journal of chemical ecology, 12(1), 147-54. https://doi.org/10.1007/BF01045598
Bottjer, K P, and Bone, L W. "Effect of combined feeding stimuli on ingestion by the nematodeTrichostrongylus colubriformis." Journal of chemical ecology vol. 12,1 (1986): 147-54. doi: https://doi.org/10.1007/BF01045598
Bottjer KP, Bone LW. Effect of combined feeding stimuli on ingestion by the nematodeTrichostrongylus colubriformis. J Chem Ecol. 1986 Jan;12(1):147-54. doi: 10.1007/BF01045598. PMID: 24306404.
Copy Download .nbib Format: NLM
Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types.

Clinica chimica acta; international journal of clinical chemistry

Nevejan L, Strypens T, Van Nieuwenhove M, Boel A, Cattoir L, Meeus P, Bossuyt X, De Neve N, Van Hoovels L.
PMID: 34919937
Clin Chim Acta. 2021 Dec 14; doi: 10.1016/j.cca.2021.12.011. Epub 2021 Dec 14.

INTRODUCTION: During the recent SARS-CoV-2 pandemic, circulating calprotectin (cCLP) gained interest as biomarker to predict the severity of COVID-19. We aimed to investigate the prognostic value of cCLP measured in serum, heparin, EDTA and citrate plasma.MATERIALS AND METHODS: COVID-19...

Cite
Nevejan L, Strypens T, Van Nieuwenhove M, et al. Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types. Clin Chim Acta. 2021;doi: 10.1016/j.cca.2021.12.011.
Nevejan, L., Strypens, T., Van Nieuwenhove, M., Boel, A., Cattoir, L., Meeus, P., Bossuyt, X., De Neve, N., & Van Hoovels, L. (2021). Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types. Clinica chimica acta; international journal of clinical chemistry, . https://doi.org/10.1016/j.cca.2021.12.011
Nevejan, Louis, et al. "Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types." Clinica chimica acta; international journal of clinical chemistry vol. (2021). doi: https://doi.org/10.1016/j.cca.2021.12.011
Nevejan L, Strypens T, Van Nieuwenhove M, Boel A, Cattoir L, Meeus P, Bossuyt X, De Neve N, Van Hoovels L. Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types. Clin Chim Acta. 2021 Dec 14; doi: 10.1016/j.cca.2021.12.011. Epub 2021 Dec 14. PMID: 34919937.
Copy Download .nbib Format: NLM
Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types.

Clinica chimica acta; international journal of clinical chemistry

Nevejan L, Strypens T, Van Nieuwenhove M, Boel A, Cattoir L, Meeus P, Bossuyt X, De Neve N, Van Hoovels L.
PMID: 34919937
Clin Chim Acta. 2021 Dec 14;525:54-61. doi: 10.1016/j.cca.2021.12.011. Epub 2021 Dec 14.

INTRODUCTION: During the recent SARS-CoV-2 pandemic, circulating calprotectin (cCLP) gained interest as biomarker to predict the severity of COVID-19. We aimed to investigate the prognostic value of cCLP measured in serum, heparin, EDTA and citrate plasma.MATERIALS AND METHODS: COVID-19...

Cite
Nevejan L, Strypens T, Van Nieuwenhove M, et al. Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types. Clin Chim Acta. 2021;525:54-61doi: 10.1016/j.cca.2021.12.011.
Nevejan, L., Strypens, T., Van Nieuwenhove, M., Boel, A., Cattoir, L., Meeus, P., Bossuyt, X., De Neve, N., & Van Hoovels, L. (2021). Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types. Clinica chimica acta; international journal of clinical chemistry, 52554-61. https://doi.org/10.1016/j.cca.2021.12.011
Nevejan, Louis, et al. "Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types." Clinica chimica acta; international journal of clinical chemistry vol. 525 (2021): 54-61. doi: https://doi.org/10.1016/j.cca.2021.12.011
Nevejan L, Strypens T, Van Nieuwenhove M, Boel A, Cattoir L, Meeus P, Bossuyt X, De Neve N, Van Hoovels L. Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types. Clin Chim Acta. 2021 Dec 14;525:54-61. doi: 10.1016/j.cca.2021.12.011. Epub 2021 Dec 14. PMID: 34919937; PMCID: PMC8669946.
Copy Download .nbib Format: NLM
Metastatic pulmonary calcification: First report of pulmonary calcium suppression using dual-energy CT.

Radiology case reports

Fehrmann A, Garcia Borrega J, Holz J, Shapira N, Doerner J, Boell B, Maintz D, Hickethier T.
PMID: 32395190
Radiol Case Rep. 2020 May 04;15(7):900-903. doi: 10.1016/j.radcr.2020.04.006. eCollection 2020 Jul.

Metastatic pulmonary calcification is an underdiagnosed metabolic lung disease characterized by diffuse calcium deposition in the lungs, often associated with secondary hyperparathyroidism due to chronic renal failure. A 31-year-old man with chronic renal failure initially presented with diffuse pain...

Cite
Fehrmann A, Garcia Borrega J, Holz J, et al. Metastatic pulmonary calcification: First report of pulmonary calcium suppression using dual-energy CT. Radiol Case Rep. 2020;15(7):900-903doi: 10.1016/j.radcr.2020.04.006.
Fehrmann, A., Garcia Borrega, J., Holz, J., Shapira, N., Doerner, J., Boell, B., Maintz, D., & Hickethier, T. (2020). Metastatic pulmonary calcification: First report of pulmonary calcium suppression using dual-energy CT. Radiology case reports, 15(7), 900-903. https://doi.org/10.1016/j.radcr.2020.04.006
Fehrmann, Ana, et al. "Metastatic pulmonary calcification: First report of pulmonary calcium suppression using dual-energy CT." Radiology case reports vol. 15,7 (2020): 900-903. doi: https://doi.org/10.1016/j.radcr.2020.04.006
Fehrmann A, Garcia Borrega J, Holz J, Shapira N, Doerner J, Boell B, Maintz D, Hickethier T. Metastatic pulmonary calcification: First report of pulmonary calcium suppression using dual-energy CT. Radiol Case Rep. 2020 May 04;15(7):900-903. doi: 10.1016/j.radcr.2020.04.006. eCollection 2020 Jul. PMID: 32395190; PMCID: PMC7203511.
Copy Download .nbib Format: NLM
Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types.

Clinica chimica acta; international journal of clinical chemistry

Nevejan L, Strypens T, Van Nieuwenhove M, Boel A, Cattoir L, Meeus P, Bossuyt X, De Neve N, Van Hoovels L.
PMID: 34919937
Clin Chim Acta. 2021 Dec 14;525:54-61. doi: 10.1016/j.cca.2021.12.011. Epub 2021 Dec 14.

INTRODUCTION: During the recent SARS-CoV-2 pandemic, circulating calprotectin (cCLP) gained interest as biomarker to predict the severity of COVID-19. We aimed to investigate the prognostic value of cCLP measured in serum, heparin, EDTA and citrate plasma.MATERIALS AND METHODS: COVID-19...

Cite
Nevejan L, Strypens T, Van Nieuwenhove M, et al. Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types. Clin Chim Acta. 2021;525:54-61doi: 10.1016/j.cca.2021.12.011.
Nevejan, L., Strypens, T., Van Nieuwenhove, M., Boel, A., Cattoir, L., Meeus, P., Bossuyt, X., De Neve, N., & Van Hoovels, L. (2021). Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types. Clinica chimica acta; international journal of clinical chemistry, 52554-61. https://doi.org/10.1016/j.cca.2021.12.011
Nevejan, Louis, et al. "Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types." Clinica chimica acta; international journal of clinical chemistry vol. 525 (2021): 54-61. doi: https://doi.org/10.1016/j.cca.2021.12.011
Nevejan L, Strypens T, Van Nieuwenhove M, Boel A, Cattoir L, Meeus P, Bossuyt X, De Neve N, Van Hoovels L. Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types. Clin Chim Acta. 2021 Dec 14;525:54-61. doi: 10.1016/j.cca.2021.12.011. Epub 2021 Dec 14. PMID: 34919937; PMCID: PMC8669946.
Copy Download .nbib Format: NLM
Human monoclonal antibodies against .

eLife

de Vor L, van Dijk B, van Kessel K, Kavanaugh JS, de Haas C, Aerts PC, Viveen MC, Boel EC, Fluit AC, Kwiecinski JM, Krijger GC, Ramakers RM, Beekman FJ, Dadachova E, Lam MG, Vogely HC, van der Wal BC, van Strijp JA, Horswill AR, Weinans H, Rooijakkers SH.
PMID: 34989676
Elife. 2022 Jan 06;11. doi: 10.7554/eLife.67301.

Implant-associated

Cite
de Vor L, van Dijk B, van Kessel K, et al. Human monoclonal antibodies against . Elife. 2022;11doi: 10.7554/eLife.67301.
de Vor, L., van Dijk, B., van Kessel, K., Kavanaugh, J. S., de Haas, C., Aerts, P. C., Viveen, M. C., Boel, E. C., Fluit, A. C., Kwiecinski, J. M., Krijger, G. C., Ramakers, R. M., Beekman, F. J., Dadachova, E., Lam, M. G., Vogely, H. C., van der Wal, B. C., van Strijp, J. A., Horswill, A. R., Weinans, H., & Rooijakkers, S. H. (2022). Human monoclonal antibodies against . eLife, 11. https://doi.org/10.7554/eLife.67301
de Vor, Lisanne, et al. "Human monoclonal antibodies against ." eLife vol. 11 (2022). doi: https://doi.org/10.7554/eLife.67301
de Vor L, van Dijk B, van Kessel K, Kavanaugh JS, de Haas C, Aerts PC, Viveen MC, Boel EC, Fluit AC, Kwiecinski JM, Krijger GC, Ramakers RM, Beekman FJ, Dadachova E, Lam MG, Vogely HC, van der Wal BC, van Strijp JA, Horswill AR, Weinans H, Rooijakkers SH. Human monoclonal antibodies against . Elife. 2022 Jan 06;11. doi: 10.7554/eLife.67301. PMID: 34989676; PMCID: PMC8751199.
Copy Download .nbib Format: NLM
Human monoclonal antibodies against .

eLife

de Vor L, van Dijk B, van Kessel K, Kavanaugh JS, de Haas C, Aerts PC, Viveen MC, Boel EC, Fluit AC, Kwiecinski JM, Krijger GC, Ramakers RM, Beekman FJ, Dadachova E, Lam MG, Vogely HC, van der Wal BC, van Strijp JA, Horswill AR, Weinans H, Rooijakkers SH.
PMID: 34989676
Elife. 2022 Jan 06;11. doi: 10.7554/eLife.67301.

Implant-associated

Cite
de Vor L, van Dijk B, van Kessel K, et al. Human monoclonal antibodies against . Elife. 2022;11doi: 10.7554/eLife.67301.
de Vor, L., van Dijk, B., van Kessel, K., Kavanaugh, J. S., de Haas, C., Aerts, P. C., Viveen, M. C., Boel, E. C., Fluit, A. C., Kwiecinski, J. M., Krijger, G. C., Ramakers, R. M., Beekman, F. J., Dadachova, E., Lam, M. G., Vogely, H. C., van der Wal, B. C., van Strijp, J. A., Horswill, A. R., Weinans, H., & Rooijakkers, S. H. (2022). Human monoclonal antibodies against . eLife, 11. https://doi.org/10.7554/eLife.67301
de Vor, Lisanne, et al. "Human monoclonal antibodies against ." eLife vol. 11 (2022). doi: https://doi.org/10.7554/eLife.67301
de Vor L, van Dijk B, van Kessel K, Kavanaugh JS, de Haas C, Aerts PC, Viveen MC, Boel EC, Fluit AC, Kwiecinski JM, Krijger GC, Ramakers RM, Beekman FJ, Dadachova E, Lam MG, Vogely HC, van der Wal BC, van Strijp JA, Horswill AR, Weinans H, Rooijakkers SH. Human monoclonal antibodies against . Elife. 2022 Jan 06;11. doi: 10.7554/eLife.67301. PMID: 34989676; PMCID: PMC8751199.
Copy Download .nbib Format: NLM
Comparison of 4 commercial enzyme immunoassays for serology testing of human parvovirus B19 infection.

Diagnostic microbiology and infectious disease

Van den Abeele T, Delforge ML, Boel A, Reynders M, Padalko E.
PMID: 34352435
Diagn Microbiol Infect Dis. 2021 Nov;101(3):115489. doi: 10.1016/j.diagmicrobio.2021.115489. Epub 2021 Jul 16.

BACKGROUND: Parvovirus B19 is a pathogenic virus often diagnosed by serology, yet little is known about analytical performance of commercial enzyme immunoassays (EIAs).OBJECTIVE: To investigate performance of 4 EIAs for parvovirus B19 IgM and IgG: Liaison, Euroimmun, Mikrogen and...

Cite
Van den Abeele T, Delforge ML, Boel A, et al. Comparison of 4 commercial enzyme immunoassays for serology testing of human parvovirus B19 infection. Diagn Microbiol Infect Dis. 2021;101(3):115489doi: 10.1016/j.diagmicrobio.2021.115489.
Van den Abeele, T., Delforge, M. L., Boel, A., Reynders, M., & Padalko, E. (2021). Comparison of 4 commercial enzyme immunoassays for serology testing of human parvovirus B19 infection. Diagnostic microbiology and infectious disease, 101(3), 115489. https://doi.org/10.1016/j.diagmicrobio.2021.115489
Van den Abeele, Tim, et al. "Comparison of 4 commercial enzyme immunoassays for serology testing of human parvovirus B19 infection." Diagnostic microbiology and infectious disease vol. 101,3 (2021): 115489. doi: https://doi.org/10.1016/j.diagmicrobio.2021.115489
Van den Abeele T, Delforge ML, Boel A, Reynders M, Padalko E. Comparison of 4 commercial enzyme immunoassays for serology testing of human parvovirus B19 infection. Diagn Microbiol Infect Dis. 2021 Nov;101(3):115489. doi: 10.1016/j.diagmicrobio.2021.115489. Epub 2021 Jul 16. PMID: 34352435.
Copy Download .nbib Format: NLM
Adaptive Behavior Scale part two: Relative severity of maladaptive behavior.

American journal of mental deficiency

Clements PR, Bost LW, DuBois YG, Turpin WB.
PMID: 7361823
Am J Ment Defic. 1980 Mar;84(5):465-9.

Part Two of the Adaptive Behavior Scale contains statements that cover 13 domains of maladaptive behavior. The present system of scoring and profiling reflects the frequency of occurrence of behavior (either occasionally or frequency) and not severity or relative...

Cite
Clements PR, Bost LW, DuBois YG, et al. Adaptive Behavior Scale part two: Relative severity of maladaptive behavior. Am J Ment Defic. 1980;84(5):465-9
Clements, P. R., Bost, L. W., DuBois, Y. G., & Turpin, W. B. (1980). Adaptive Behavior Scale part two: Relative severity of maladaptive behavior. American journal of mental deficiency, 84(5), 465-9.
Clements, P R, et al. "Adaptive Behavior Scale part two: Relative severity of maladaptive behavior." American journal of mental deficiency vol. 84,5 (1980): 465-9.
Clements PR, Bost LW, DuBois YG, Turpin WB. Adaptive Behavior Scale part two: Relative severity of maladaptive behavior. Am J Ment Defic. 1980 Mar;84(5):465-9. PMID: 7361823.
Copy Download .nbib Format: NLM
Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types.

Clinica chimica acta; international journal of clinical chemistry

Nevejan L, Strypens T, Van Nieuwenhove M, Boel A, Cattoir L, Meeus P, Bossuyt X, De Neve N, Van Hoovels L.
PMID: 34919937
Clin Chim Acta. 2021 Dec 14;525:54-61. doi: 10.1016/j.cca.2021.12.011. Epub 2021 Dec 14.

INTRODUCTION: During the recent SARS-CoV-2 pandemic, circulating calprotectin (cCLP) gained interest as biomarker to predict the severity of COVID-19. We aimed to investigate the prognostic value of cCLP measured in serum, heparin, EDTA and citrate plasma.MATERIALS AND METHODS: COVID-19...

Cite
Nevejan L, Strypens T, Van Nieuwenhove M, et al. Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types. Clin Chim Acta. 2021;525:54-61doi: 10.1016/j.cca.2021.12.011.
Nevejan, L., Strypens, T., Van Nieuwenhove, M., Boel, A., Cattoir, L., Meeus, P., Bossuyt, X., De Neve, N., & Van Hoovels, L. (2021). Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types. Clinica chimica acta; international journal of clinical chemistry, 52554-61. https://doi.org/10.1016/j.cca.2021.12.011
Nevejan, Louis, et al. "Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types." Clinica chimica acta; international journal of clinical chemistry vol. 525 (2021): 54-61. doi: https://doi.org/10.1016/j.cca.2021.12.011
Nevejan L, Strypens T, Van Nieuwenhove M, Boel A, Cattoir L, Meeus P, Bossuyt X, De Neve N, Van Hoovels L. Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types. Clin Chim Acta. 2021 Dec 14;525:54-61. doi: 10.1016/j.cca.2021.12.011. Epub 2021 Dec 14. PMID: 34919937; PMCID: PMC8669946.
Copy Download .nbib Format: NLM
Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme.

Diagnostic microbiology and infectious disease

Moerman A, Vernelen K, China B, Capron A, Bossche DVD, Mariën J, Ariën KK, Van Acker J, Delforge ML, Reynders M, Boel A, Depypere M, Van Gasse N, Vijgen S, Brauner J, Dujardin B, Padalko E.
PMID: 34773801
Diagn Microbiol Infect Dis. 2021 Oct 11;102(2):115561. doi: 10.1016/j.diagmicrobio.2021.115561. Epub 2021 Oct 11.

We report on sample IS/17575 since it generated highly divergent results in the Belgian SARS-CoV-2 serology external quality assessment scheme. Sample IS/17575 was serum originating from a 30 years old male patient. 124 diagnostic laboratories analysed this sample. A...

Cite
Moerman A, Vernelen K, China B, et al. Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme. Diagn Microbiol Infect Dis. 2021;102(2):115561doi: 10.1016/j.diagmicrobio.2021.115561.
Moerman, A., Vernelen, K., China, B., Capron, A., Bossche, D. V. D., Mariën, J., Ariën, K. K., Van Acker, J., Delforge, M. L., Reynders, M., Boel, A., Depypere, M., Van Gasse, N., Vijgen, S., Brauner, J., Dujardin, B., & Padalko, E. (2021). Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme. Diagnostic microbiology and infectious disease, 102(2), 115561. https://doi.org/10.1016/j.diagmicrobio.2021.115561
Moerman, Alena, et al. "Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme." Diagnostic microbiology and infectious disease vol. 102,2 (2021): 115561. doi: https://doi.org/10.1016/j.diagmicrobio.2021.115561
Moerman A, Vernelen K, China B, Capron A, Bossche DVD, Mariën J, Ariën KK, Van Acker J, Delforge ML, Reynders M, Boel A, Depypere M, Van Gasse N, Vijgen S, Brauner J, Dujardin B, Padalko E. Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme. Diagn Microbiol Infect Dis. 2021 Oct 11;102(2):115561. doi: 10.1016/j.diagmicrobio.2021.115561. Epub 2021 Oct 11. PMID: 34773801; PMCID: PMC8503966.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 90 entries